Computable Genomix to release new online genomics research tool

NewsGuard 100/100 Score

Memphis-based Computable Genomix today announced it will launch a contest on Oct. 1, 2009, to coincide with the release of GeneIndexer, the company’s next-generation Web-based text-mining tool.

Publish or Perish will award a $10,000 grant to each of the first three researchers to publish a discovery made using the online genomics research tool GeneIndexer. Interested researchers should register for the contest by Dec. 31, 2009. In order to conduct their research, entrants will receive a free one-month subscription to GeneIndexer and will have the opportunity to participate in two training Webinars to be held Oct. 27 and Nov. 10, 2009, addressing the use of GeneIndexer for discoveries using high-throughput genomic data.

“Our mission is to help researchers more quickly and efficiently use Medline abstracts to make discoveries with high-throughput genomic data,” said Brad Silver, chief executive officer of Computable Genomix. “We thought Publish or Perish would be a fun way to introduce GeneIndexer to researchers so they could incorporate it into their research process.”

In addition to the grant, winners will be reimbursed for journal publication fees and will receive one free annual subscription to GeneIndexer. More information about the Publish or Perish contest, including registration details, criteria, deadlines, and contest updates, can be found at www.geneindexercontest.com.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies